← Leaderboards

Gayle E Woloschak

University Of Chicago

Google Scholar ↗PubMed ↗ORCID ↗

$21,789,151

Attributed

$21,789,151

Total exposure

25

Grants

23

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $4.4M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$28,250,839 · 25

CDC$2,218,631 · 1

By mechanism

P01$14,891,306 · 9

R01$8,387,907 · 5

S10$2,866,125 · 1

R25$1,961,238 · 1

T32$1,178,358 · 1

U54$1,043,209 · 2

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsProgramsCellsFundingAnimal ModelResearch PersonnelRoentgen RaysEvaluationImageChemistryCommunitiesBiologicalExposure ToRadiationTraining ProgramsMedicalNanotechnologyLaboratory MouseMeetingsBaseRadioisotopesCollaborationsIn VivoNanoparticle

Grant awards (83)

Multi-Scale Evaluation and Mitigation of Toxicities Following Internal Radionuclide Contamination$2,107,110

P01 · FY2025 · AI · contact PI

Project-004$514,890

P01 · FY2025 · AI · contact PI

Project-003$440,169

P01 · FY2025 · AI · contact PI

Project-002$297,176

P01 · FY2025 · AI · contact PI

Core-001$254,733

P01 · FY2025 · AI · contact PI

Admin-Core-001$217,366

P01 · FY2025 · AI · contact PI

Multi-Scale Evaluation and Mitigation of Toxicities Following Internal Radionuclide Contamination$2,112,409

P01 · FY2024 · AI · contact PI

Project-004$646,143

P01 · FY2024 · AI · contact PI

Project-003$461,756

P01 · FY2024 · AI · contact PI

Project-002$433,026

P01 · FY2024 · AI · contact PI

Core-001$338,069

P01 · FY2024 · AI · contact PI

Admin-Core-001$233,415

P01 · FY2024 · AI · contact PI

Multi-Scale Evaluation and Mitigation of Toxicities Following Internal Radionuclide Contamination$64,077

P01 · FY2024 · AI · contact PI

Admin-Core-001$64,077

P01 · FY2024 · AI · contact PI

Multi-Scale Evaluation and Mitigation of Toxicities Following Internal Radionuclide Contamination$2,150,006

P01 · FY2023 · AI · contact PI

Project 3: Elemental Microscopy for Detection of Radionuclide Distribution and Development of Cell and Tissue Phantoms$406,607

P01 · FY2023 · AI · contact PI

Administrative Core$191,784

P01 · FY2023 · AI · contact PI

Dosimetry and health effects of internal radionuclides$8,000

R13 · FY2023 · AI · contact PI

Multi-Scale Evaluation and Mitigation of Toxicities Following Internal Radionuclide Contamination$2,246,717

P01 · FY2022 · AI · contact PI

Administrative Core$374,454

P01 · FY2022 · AI · contact PI

Project 3: Elemental Microscopy for Detection of Radionuclide Distribution and Development of Cell and Tissue Phantoms$374,452

P01 · FY2022 · AI · contact PI

Radiation induced cancer risk reduction as a function of dose protraction: interspecies comparison$335,750

R01 · FY2021 · CA · contact PI

Radiation induced cancer risk reduction as a function of dose protraction: interspecies comparison$335,750

R01 · FY2020 · CA · contact PI

Radiation induced cancer risk reduction as a function of dose protraction: interspecies comparison$325,677

R01 · FY2019 · CA · contact PI

Cancer Nanotechnology Training Program$256,059

T32 · FY2019 · CA · contact PI

Radiation induced cancer risk reduction as a function of dose protraction: interspecies comparison$335,750

R01 · FY2018 · CA · contact PI

Cancer Nanotechnology Training Program$266,184

T32 · FY2018 · CA · contact PI

Radiation induced cancer risk reduction as a function of dose protraction: interspecies comparison$335,484

R01 · FY2017 · CA · contact PI

Cancer Nanotechnology Training Program$259,211

T32 · FY2017 · CA · contact PI

Cancer Nanotechnology Training Program$7,642

T32 · FY2017 · CA · contact PI

The roles of TfRs and HSPA5 in Pu uptake$551,421

R01 · FY2016 · OH · contact PI

Cancer Nanotechnology Training Program$254,978

T32 · FY2016 · CA · contact PI

The roles of TfRs and HSPA5 in Pu uptake$550,741

R01 · FY2015 · OH · contact PI

Cancer Nanotechnology Training Program$134,284

T32 · FY2015 · CA · contact PI

The roles of TfRs and HSPA5 in Pu uptake$551,668

R01 · FY2014 · OH · contact PI

Education/Training and Outreach Activities$42,339

U54 · FY2014 · CA · contact PI

Radiation Research Society Annual Meeting$3,500

R13 · FY2014 · CA · contact PI

Cancer Nanotechnology in Imaging and Radiotherapy$409,771

R25 · FY2013 · CA · contact PI

The roles of TfRs and HSPA5 in Pu uptake$350,979

R01 · FY2013 · OH · contact PI

Applications of Core-Shell Ti02 Nanoconjugates$311,013

R01 · FY2013 · EB · contact PI

The roles of TfRs and HSPA5 in Pu uptake$213,822

R01 · FY2013 · OH · contact PI

Education/Training and Outreach Activities$39,764

U54 · FY2013 · CA · contact PI

X-ray Fluorescence Microscopy (XFM) in Biology$7,000

R13 · FY2013 · EB · contact PI

Education/Training and Outreach Activities$5,396

U54 · FY2013 · CA · contact PI

Applications of Core-Shell Ti02 Nanoconjugates$329,812

R01 · FY2012 · EB · contact PI

Cancer Nanotechnology in Imaging and Radiotherapy$209,218

R25 · FY2012 · CA · contact PI

Education/Training and Outreach Activities$51,246

U54 · FY2012 · CA · contact PI

Cancer Nanotechnology in Imaging and Radiotherapy$467,264

R25 · FY2011 · CA · contact PI

Applications of Core-Shell Ti02 Nanoconjugates$329,812

R01 · FY2011 · EB · contact PI

Education/Training and Outreach Activities$44,747

U54 · FY2011 · CA · contact PI

Nanoprobe for High Resolution Hard X-ray Fluorescence Microscopy$2,866,125

S10 · FY2010 · RR · contact PI

Cancer Nanotechnology in Imaging and Radiotherapy$540,926

R25 · FY2010 · CA · contact PI

Applications of Core-Shell Ti02 Nanoconjugates$343,125

R01 · FY2010 · EB · contact PI

Education/Training and Outreach Activities$45,000

U54 · FY2010 · CA · contact PI

IMAGING NANOPARTICLES FOR DIAGNOSTIC & THERAPEUTIC USE IN MOUSE TISSUES BY XFM$16,209

P41 · FY2010 · RR · contact PI

TiO2 nanocomposites for Targeted Treatment and Imaging of Prostate cancer$485,759

U54 · FY2009 · CA · contact PI

Cancer Nanotechnology in Imaging and Radiotherapy$334,059

R25 · FY2009 · CA · contact PI

SAXS STUDIES OF CONJGATED TITANIUM DIOXIDE NANO PARTICLES$6,487

P41 · FY2009 · RR · contact PI

TiO2 nanocomposites for Targeted Treatment and Imaging of Prostate cancer$328,958

U54 · FY2008 · CA · contact PI

Applications of TiO2-DNA nanocomposites$283,791

R01 · FY2008 · EB · contact PI

IMAGING NANOPARTICLES FOR DIAGNOSTIC & THERAPEUTIC USE IN MOUSE TISSUES BY XFM$82,314

P41 · FY2008 · RR · contact PI

Applications of TiO2-DNA nanocomposites$285,130

R01 · FY2007 · EB · contact PI

Applications of TiO2-DNA nanocomposites$293,645

R01 · FY2006 · EB · contact PI

Application of TiO2-DNA nanocomposites to Cancer Cells$237,817

R01 · FY2006 · CA · contact PI

Application of TiO2-DNA nanocomposites to Cancer Cells$80,252

R01 · FY2006 · CA · contact PI

DETECTION OF TITANIUM DIOXIDE NANOCOMPOSITES IN CULTURED CELLS AND TISSUES$17,817

P41 · FY2006 · RR · contact PI

Applications of TiO2-DNA nanocomposites$300,713

R01 · FY2005 · EB

Application of TiO2-DNA nanocomposites to Cancer Cells$243,540

R01 · FY2005 · CA

Application of TiO2-DNA nanocomposites to Cancer Cells$78,347

R01 · FY2005 · CA

Application of TiO2-DNA nanocomposites to Cancer Cells$243,540

R01 · FY2004 · CA

Application of TiO2-DNA nanocomposites to Cancer Cells$76,498

R01 · FY2004 · CA

PCNA PROMOTER DELETION IN RADIOSENSITIVE MICE$183,403

R01 · FY2003 · CA

PCNA PROMOTER DELETION IN RADIOSENSITIVE MICE$234,143

R01 · FY2002 · CA

PCNA PROMOTER DELETION IN RADIOSENSITIVE MICE$80,345

R01 · FY2002 · CA

PATHOGENESIS OF MOTOR NEURON DISEASE$73,467

P01 · FY2002 · NS

PCNA PROMOTER DELETION IN RADIOSENSITIVE MICE$2,379

R01 · FY2002 · CA

PATHOGENESIS OF MOTOR NEURON DISEASE$293,069

P01 · FY2001 · NS

PCNA PROMOTER DELETION IN RADIOSENSITIVE MICE$263,302

R01 · FY2001 · CA

PATHOGENESIS OF MOTOR NEURON DISEASE$73,467

P01 · FY2001 · NS

PCNA PROMOTER DELETION IN RADIOSENSITIVE MICE$44,625

R01 · FY2001 · CA

PATHOGENESIS OF MOTOR NEURON DISEASE$293,069

P01 · FY2000 · NS

PCNA PROMOTER DELETION IN RADIOSENSITIVE MICE$255,633

R01 · FY2000 · CA

PATHOGENESIS OF MOTOR NEURON DISEASE$229,798

P01 · FY2000 · NS